Status:
COMPLETED
Prevention of Contrast Induced Nephropathy (NIC) by Intravenous Versus Oral Rehydration
Lead Sponsor:
Clinica Universidad de Navarra, Universidad de Navarra
Conditions:
KIDNEY FAILURE, ACUTE
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to compare the efficacy of oral versus intravenous hydration in the prevention of the contrast-induced nephropathy.
Detailed Description
Objective: To compare the efficacy of oral versus intravenous hydration in the prevention of the contrast-induced nephropathy (CIN) in inpatients with different renal function and equal type and volum...
Eligibility Criteria
Inclusion
- Hospitalized patients
- aged less than 18 years
- provision for the performance of IV contrast (120-150 ml) within 12-24 h.
Exclusion
- Nephropathy patients with stage 4-5 according to the classification of Chronic Kidney Disease (CKD) of the U.S. National Kidney Foundation's Kidney Disease Outcome Quality Initiative (NKF-KDOQI). The GFR is estimated by the formula Modification Diet Renal Diseases Study (MDRD).
- Patients undergoing: cardiac catheterization or other proceeding in contrast with the previous week, colonoscopy in 48 hours or have received prior nephrotoxic (aminoglycosides and / or certain chemotherapeutic agents) 24-48 hours before the test or in hours.
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
167 Patients enrolled
Trial Details
Trial ID
NCT00908843
Start Date
September 1 2008
End Date
June 1 2012
Last Update
June 8 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinica Universidad de Navarra
Pamplona, Navarre, Spain, 31008